Advertisement

Topics

Netherlands Genomics Initiative NGI Company Profile

04:38 EST 25th November 2017 | BioPortfolio

NGI has released its Strategic Plan 2008 - 2012. Central elements of the plan are continuation of the national approach to genomics, increased emphasis on social and economic returns, and further strengthening of the knowledge base (research, technology and education).

Location

P.O. Box 93035
The Hague
2509 AA
Netherlands

Contact

Phone: 31 70 344 0672, +31 70 344 0640
Fax: 31 70 344 0632
Email: info@genomics.nl


News Articles [756 Associated News Articles listed on BioPortfolio]

Recognitions for Contributions in Genomics by Dan David Prize Awards

Recognitions for Contributions in Genomics by Dan David Prize Awards Reporter: Aviva Lev-Ari, PhD, RN   The Source for this List is a Search for “Genomics” on the Dan David Prize webs...

TGen develops processing procedures for 'single-cell' sequencing

(The Translational Genomics Research Institute) The Translational Genomics Research Institute (TGen) today announced grant support from the Chan Zuckerberg Initiative (CZI) donor advised fund, an advi...

Researchers discover a crucial gene involved in the development of the placenta

A massive genomics study of people with intellectual disabilities performed in the Netherlands points to patient mutations in the TLK2 gene.

FILM: What Next for Genomics?

This film documents the Progress Educational Trust/Genomics England event 'What Next for Genomics? Providing Answers, Changing Lives, Transforming the NHS', which launched the Chief Medical Officer's ...

From Bedside Back to Bench: Bringing Genomic Medicine Full Circle

August is a quiet month in D.C., but once the fall begins, our heads will spin with important events: the last Fiscal Year 2016 meeting of the National Advisory Council for Human Genome Research, deve...

Rosetta Genomics Ltd.: Rosetta Genomics Announces Pricing of $2.73 Million Financing

PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / August 4, 2017 / Rosetta Genomics Ltd. (NASDAQ: ROSG), a genomic diagnostics company that improves treatment decisions by providing timely and ac...

Euthanasia Used for 4.5 Percent of Deaths in the Netherlands

(ABC News) – Euthanasia has become “common practice” in the Netherlands, accounting for 4.5 percent of deaths, according to researchers who say requests are increasing from people wh...

NIH Investigating Genomics in Rare Eye Diseases, Fast Tracking Treatments

The National Ophthalmic Disease Genotyping and Phenotyping Network (eyeGENE®) is a genomic medicine initiative created by the National Eye Institute (NEI), part of the National... Read More →

PubMed Articles [678 Associated PubMed Articles listed on BioPortfolio]

An irregular atrial tachycardia : What is the underlying mechanism?

An irregular atrial tachycardia : What is the underlying mechanism?

A 46-year-old man with recurrent embolic events.

Genomics Education: Knowledge of Nurses Across the Profession and Integration Into Practice.

Since the completion of the Human Genome Project in 2003, the implications of genetics and genomics for health and illness have become clearer. All nurses, at all levels and across all specialties, mu...

Genetics and Genomics: An Oncology Nurse's Journey in Practice.

Cancer genetics and genomics are now an integral component of oncology care. Genetics and genomics guide recommendations not only for cancer prevention and early detection, but also for cancer treatme...

Clinical Trials [411 Associated Clinical Trials listed on BioPortfolio]

Modified Natural Cycle Offers a Chance of Pregnancy in Patients With Poor Response to IVF Drugs

The purpose of this study is to evaluate the effectiveness of a modified natural cycle in patients with previous poor response to infertility drugs, prior to proceeding to oocyte donation ...

Resuscitation Outcomes in the Netherlands

The Resuscitation Outcomes in the Netherlands - study assesses one-year survival and quality of life after In-Hospital Cardiac Arrest(IHCA). It's design is a multicenter prospective observ...

Quality Initiative in Rectal Cancer (QIRC) Trial

The Quality initiative in rectal cancer (QIRC) trial will test if a strategy designed to positively influence surgeon practice can decrease hospital rates of permanent colostomy and local ...

VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands

The main purpose of this study is to evaluate safety and effectiveness of the treatment of multiple myeloma with bortezomib in daily practice in the Netherlands.

Eisenmenger Quality Enhancement Research Initiative

Eisenmenger Quality Enhancement Research Initiative (QuERI) is a multi-center, observational, US-based longitudinal program, with enrollment of consecutive Eisenmenger patients who meet en...

Companies [847 Associated Companies listed on BioPortfolio]

Netherlands Genomics Initiative NGI

NGI has released its Strategic Plan 2008 - 2012. Central elements of the plan are continuation of the national approach to genomics, increased emphasis on social and economic returns, and further stre...

InteRNA Genomics

InteRNA Genomics B.V., a subsidiary of InteRNA Technologies B.V. and based in Bilthoven, the Netherlands, offers services and software for processing, analyzing and presenting ultra-high-throughpu...

Dyadic Nederland BV

Dyadic Netherlands is a wholly owned subsidiary of Dyadic based in Wageningen, the Netherlands that is dedicated to research and development activities for the benefit of Dyadic, ...

Genomics in Business

In 2003 Keygene initiated the first edition of Genomics in Business. It was the first conference to focus on the existing and future applications of genomics in the Agro-Food industry. With participan...

Genomics One Corporation

Genomics One is a fully integrated biotechnology company committed to the creation of shareholder value through innovation in the fields of genomics, proteomics and mono-clonal antibodies. The mission...

More Information about "Netherlands Genomics Initiative NGI" on BioPortfolio

We have published hundreds of Netherlands Genomics Initiative NGI news stories on BioPortfolio along with dozens of Netherlands Genomics Initiative NGI Clinical Trials and PubMed Articles about Netherlands Genomics Initiative NGI for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Netherlands Genomics Initiative NGI Companies in our database. You can also find out about relevant Netherlands Genomics Initiative NGI Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record